\n\t\t\tJournalists in 50+ countries follow the constant flow of money made and lost in oil & gas while\n\t\t\ttracking emerging trends and opportunities in the future of energy. Don’t miss our exclusive\n\t\t\tnewsletter, Energy Source.\n\t\t
Journalists in 50+ countries follow the constant flow of money made and lost in oil & gas while tracking emerging trends and opportunities in the future of energy. Don’t miss our exclusive newsletter, Energy Source.
Try full digital access and see why over 1 million readers subscribe to the FTÖsterreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study - BMC CancerBackground Treatment of cancer patients in certified cancer centers, that meet specific quality standards in term of structures and procedures of medical care, is a national treatment goal in Germany. However, convincing evidence that treatment in certified cancer centers is associated with better outcomes in patients with pancreatic cancer is still missing. Methods We used patient-specific information (demographic characteristics, diagnoses, treatments) from German statutory health insurance data covering the period 2009–2017 and hospital characteristics from the German Standardized Quality Reports. We investigated differences in survival between patients treated in hospitals with and without pancreatic cancer center certification by the German Cancer Society (GCS) using the Kaplan–Meier estimator and Cox regression with shared frailty. Results The final sample included 45,318 patients with pancreatic cancer treated in 1,051 hospitals (96 GCS-certified, 955 not GCS-certified). 5,426 (12.0%) of the patients were treated in GCS-certified pancreatic cancer centers. Patients treated in certified and non-certified hospitals had similar distributions of age, sex, and comorbidities. Median survival was 8.0 months in GCS-certified pancreatic cancer centers and 4.4 months in non-certified hospitals. Cox regression adjusting for multiple patient and hospital characteristics yielded a significantly lower hazard of long-term, all-cause mortality in patients treated in GCS-certified pancreatic centers (Hazard ratio = 0.89; 95%-CI = 0.85–0.93). This result remained robust in multiple sensitivity analyses, including stratified estimations for subgroups of patients and hospitals. Conclusion This robust observational evidence suggests that patients with pancreatic cancer benefit from treatment in a certified cancer center in terms of survival. Therefore, the certification of hospitals appears to be a powerful strategy to improve patient outcomes in pancreatic cancer care. Trial reg
Weiterlesen »
'Lunatic' Putin has 'small man syndrome' - minister saysBoris Johnson told German TV that Vladimir Putin would not have started the “crazy, macho” war in Ukraine if he were a woman
Weiterlesen »
Russia's Killnet hacking group has started attacking LithuaniaA group of Russian hackers have started to target Lithuania as they aim to shut down government websites and cause chaos.
Weiterlesen »
Jilted mum, 32, threatened to share X-rated vids after she started dating her exA JILTED mum bombarded a lawyer with threatening messages at work after she started dating her ex, a court heard. Kayleigh Gordon, 32, claimed she had explicit footage of Beth Mantel with her ex Ri…
Weiterlesen »